Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  COVID-19

  Free Subscription


Articles published in J Med Virol

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    March 2020
  1. WAN S, Xiang Y, Fang W, Zheng Y, et al
    Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing.
    J Med Virol. 2020 Mar 21. doi: 10.1002/jmv.25783.
    PubMed     Text format     Abstract available


  2. DING Q, Lu P, Fan Y, Xia Y, et al
    The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China.
    J Med Virol. 2020 Mar 20. doi: 10.1002/jmv.25781.
    PubMed     Text format     Abstract available


  3. AGYEMAN AA, Laar A, Ofori-Asenso R
    Will COVID-19 be a litmus test for post-Ebola Sub-Saharan Africa?
    J Med Virol. 2020 Mar 20. doi: 10.1002/jmv.25780.
    PubMed     Text format     Abstract available


  4. GIOVANETTI M, Angeletti S, Benvenuto D, Ciccozzi M, et al
    A doubt of multiple introduction of SARS-CoV-2 in Italy: a preliminary overview.
    J Med Virol. 2020 Mar 19. doi: 10.1002/jmv.25773.
    PubMed     Text format     Abstract available


  5. LU S, Lin J, Zhang Z, Xiao L, et al
    Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.
    J Med Virol. 2020 Mar 19. doi: 10.1002/jmv.25776.
    PubMed     Text format     Abstract available


  6. GAO Y, Li T, Han M, Li X, et al
    Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19.
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25770.
    PubMed     Text format     Abstract available


  7. JIAO J
    Under the epidemic situation of COVID-19, should special attention to pregnant women be given?
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25771.
    PubMed     Text format     Abstract available


  8. QU R, Ling Y, Zhang YH, Wei LY, et al
    Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19.
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25767.
    PubMed     Text format     Abstract available


  9. DONG S, Sun J, Mao Z, Wang L, et al
    A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV).
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25768.
    PubMed     Text format     Abstract available


  10. CIMOLAI N
    Potentially repurposing adamantanes for COVID-19.
    J Med Virol. 2020 Mar 16. doi: 10.1002/jmv.25752.
    PubMed     Text format    


  11. PENG Y, Zhou YH
    Is novel coronavirus disease (COVID-19) transmitted through conjunctiva?
    J Med Virol. 2020 Mar 16. doi: 10.1002/jmv.25753.
    PubMed     Text format    


  12. HE F, Deng Y, Li W
    Coronavirus Disease 2019 (COVID-19): What we know?
    J Med Virol. 2020 Mar 14. doi: 10.1002/jmv.25766.
    PubMed     Text format     Abstract available


  13. ZHU W, Xie K, Lu H, Xu L, et al
    Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China.
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25763.
    PubMed     Text format     Abstract available


  14. WANG C, Liu Z, Chen Z, Huang X, et al
    The establishment of reference sequence for SARS-CoV-2 and variation analysis.
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25762.
    PubMed     Text format     Abstract available


  15. LUNG J, Lin YS, Yang YH, Chou YL, et al
    The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25761.
    PubMed     Text format     Abstract available


  16. CARDENAS-CONEJO Y, Linan-Rico A, Garcia-Rodriguez DA, Centeno-Leija S, et al
    An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV2).
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25758.
    PubMed     Text format     Abstract available


  17. LI LQ, Huang T, Wang YQ, Wang ZP, et al
    2019 novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis.
    J Med Virol. 2020 Mar 12. doi: 10.1002/jmv.25757.
    PubMed     Text format     Abstract available


  18. CHEN Q, Quan B, Li X, Gao G, et al
    A report of clinical diagnosis and treatment of 9 cases of coronavirus disease 2019.
    J Med Virol. 2020 Mar 12. doi: 10.1002/jmv.25755.
    PubMed     Text format     Abstract available


  19. ZHU F, Cao Y, Xu S, Zhou M, et al
    Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25732.
    PubMed     Text format    


  20. KANDEEL M, Ibrahim AA, Fayez M, Al-Nazawi M, et al
    From SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and non-structural genes.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25754.
    PubMed     Text format     Abstract available


  21. CONWAY MJ
    Identification of Coronavirus Sequences in Carp cDNA from Wuhan, China.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25751.
    PubMed     Text format     Abstract available


  22. FANG Y, Nie Y, Penny M
    Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis.
    J Med Virol. 2020 Mar 6. doi: 10.1002/jmv.25750.
    PubMed     Text format     Abstract available


  23. HAN Y, Yang H
    The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective.
    J Med Virol. 2020 Mar 6. doi: 10.1002/jmv.25749.
    PubMed     Text format     Abstract available


  24. WANG Y, Wang Y, Chen Y, Qin Q, et al
    Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
    J Med Virol. 2020 Mar 5. doi: 10.1002/jmv.25748.
    PubMed     Text format     Abstract available


  25. ZHANG J, Wang S, Xue Y
    Fecal specimen diagnosis 2019 Novel Coronavirus-Infected Pneumonia.
    J Med Virol. 2020 Mar 3. doi: 10.1002/jmv.25742.
    PubMed     Text format     Abstract available


  26. DEY SK, Rahman MM, Siddiqi UR, Howlader A, et al
    Analyzing the Epidemiological Outbreak of COVID-19: A Visual Exploratory Data Analysis (EDA) Approach.
    J Med Virol. 2020 Mar 3. doi: 10.1002/jmv.25743.
    PubMed     Text format     Abstract available


  27. LU Q, Shi Y
    Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.
    J Med Virol. 2020 Mar 1. doi: 10.1002/jmv.25740.
    PubMed     Text format     Abstract available


  28. LU H, Stratton CW, Tang YW
    The Wuhan SARS-CoV-2 - What's Next for China.
    J Med Virol. 2020 Mar 1. doi: 10.1002/jmv.25738.
    PubMed     Text format     Abstract available


    February 2020
  29. BHATTACHARYA M, Ranjan Sharma A, Patra P, Ghosh P, et al
    Development of epitope-based peptide vaccine against novel Coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    J Med Virol. 2020 Feb 28. doi: 10.1002/jmv.25736.
    PubMed     Text format     Abstract available


  30. ZHANG Q, Wang Y, Qi C, Shen L, et al
    Clinical trial analysis of 2019-nCoV therapy registered in China.
    J Med Virol. 2020 Feb 28. doi: 10.1002/jmv.25733.
    PubMed     Text format     Abstract available


  31. SUN P, Qie S, Liu Z, Ren J, et al
    Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection.
    J Med Virol. 2020 Feb 28. doi: 10.1002/jmv.25735.
    PubMed     Text format     Abstract available


  32. LI Z, Yi Y, Luo X, Xiong N, et al
    Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25727.
    PubMed     Text format     Abstract available


  33. LI YC, Bai WZ, Hashikawa T
    The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25728.
    PubMed     Text format     Abstract available


  34. LI X, Zai J, Zhao Q, Nie Q, et al
    Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25731.
    PubMed     Text format     Abstract available


  35. YAO TT, Qian JD, Zhu WY, Wang Y, et al
    A Systematic Review of Lopinavir Therapy for SARS Coronavirus and MERS Coronavirus-A Possible Reference for Coronavirus Disease-19 Treatment Option.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25729.
    PubMed     Text format     Abstract available


  36. LIU Z, Xiao X, Wei X, Li J, et al
    Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
    J Med Virol. 2020 Feb 26. doi: 10.1002/jmv.25726.
    PubMed     Text format     Abstract available


  37. XIA J, Tong J, Liu M, Shen Y, et al
    Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection.
    J Med Virol. 2020 Feb 26. doi: 10.1002/jmv.25725.
    PubMed     Text format     Abstract available


  38. SUN P, Lu X, Xu C, Sun W, et al
    Understanding of COVID-19 based on current evidence.
    J Med Virol. 2020 Feb 25. doi: 10.1002/jmv.25722.
    PubMed     Text format     Abstract available


  39. LAI A, Bergna A, Acciarri C, Galli M, et al
    Early Phylogenetic Estimate of the Effective Reproduction Number Of Sars-CoV-2.
    J Med Virol. 2020 Feb 25. doi: 10.1002/jmv.25723.
    PubMed     Text format     Abstract available


  40. WANG Y, Kang H, Liu X, Tong Z, et al
    Combination of RT-qPCR Testing and Clinical Features For Diagnosis of COVID-19 facilitates management of SARS-CoV-2 Outbreak.
    J Med Virol. 2020 Feb 25. doi: 10.1002/jmv.25721.
    PubMed     Text format     Abstract available


  41. YANG Y, Shang W, Rao X
    Facing the COVID-19 outbreak: What should we know and what could we do?
    J Med Virol. 2020 Feb 24. doi: 10.1002/jmv.25720.
    PubMed     Text format     Abstract available


  42. HAN W, Quan B, Guo Y, Zhang J, et al
    The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019.
    J Med Virol. 2020 Feb 19. doi: 10.1002/jmv.25711.
    PubMed     Text format     Abstract available


  43. LIU J, Zheng X, Tong Q, Li W, et al
    Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25709.
    PubMed     Text format     Abstract available


  44. JIANG X, Rayner S, Luo MH
    Does SARS-CoV-2 has a longer incubation period than SARS and MERS?
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25708.
    PubMed     Text format     Abstract available


  45. ZHANG L, Liu Y
    Potential Interventions for Novel Coronavirus in China: A Systemic Review.
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25707.
    PubMed     Text format     Abstract available


  46. GUAN W, Xian J
    The progress of 2019 Novel Coronavirus (2019-nCoV) event in China.
    J Med Virol. 2020 Feb 12. doi: 10.1002/jmv.25705.
    PubMed     Text format     Abstract available


  47. AYITTEY FK, Ayittey MK, Chiwero NB, Kamasah JS, et al
    Economic Impacts of Wuhan 2019-nCoV on China and the World.
    J Med Virol. 2020 Feb 12. doi: 10.1002/jmv.25706.
    PubMed     Text format     Abstract available


  48. XIAO SY, Wu Y, Liu H
    Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary/Review].
    J Med Virol. 2020 Feb 7. doi: 10.1002/jmv.25702.
    PubMed     Text format     Abstract available


  49. CERAOLO C, Giorgi FM
    Genomic variance of the 2019-nCoV coronavirus.
    J Med Virol. 2020 Feb 6. doi: 10.1002/jmv.25700.
    PubMed     Text format     Abstract available


  50. LI X, Wang W, Zhao X, Zai J, et al
    Transmission dynamics and evolutionary history of 2019-nCoV.
    J Med Virol. 2020 Feb 6. doi: 10.1002/jmv.25701.
    PubMed     Text format     Abstract available


  51. BARUAH V, Bose S
    Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.
    J Med Virol. 2020 Feb 5. doi: 10.1002/jmv.25698.
    PubMed     Text format     Abstract available


  52. GIOVANETTI M, Benvenuto D, Angeletti S, Ciccozzi M, et al
    The first two cases of 2019-nCoV in Italy: where they come from?
    J Med Virol. 2020 Feb 5. doi: 10.1002/jmv.25699.
    PubMed     Text format     Abstract available


  53. KOFI AYITTEY F, Dzuvor C, Kormla Ayittey M, Bennita Chiwero N, et al
    Updates on Wuhan 2019 Novel Coronavirus Epidemic.
    J Med Virol. 2020 Feb 4. doi: 10.1002/jmv.25695.
    PubMed     Text format     Abstract available


    January 2020
  54. LI X, Zai J, Wang X, Li Y, et al
    Potential of large 'first generation' human-to-human transmission of 2019-nCoV.
    J Med Virol. 2020 Jan 30. doi: 10.1002/jmv.25693.
    PubMed     Text format     Abstract available


  55. WANG W, Tang J, Wei F
    Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.
    J Med Virol. 2020 Jan 29. doi: 10.1002/jmv.25689.
    PubMed     Text format     Abstract available


  56. BENVENUTO D, Giovanetti M, Ciccozzi A, Spoto S, et al
    The 2019-new coronavirus epidemic: Evidence for virus evolution.
    J Med Virol. 2020 Jan 29. doi: 10.1002/jmv.25688.
    PubMed     Text format     Abstract available


  57. CHEN Y, Liu Q, Guo D
    Emerging coronaviruses: Genome structure, replication, and pathogenesis.
    J Med Virol. 2020 Jan 22. doi: 10.1002/jmv.25681.
    PubMed     Text format     Abstract available


  58. JI W, Wang W, Zhao X, Zai J, et al
    Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human.
    J Med Virol. 2020 Jan 22. doi: 10.1002/jmv.25682.
    PubMed     Text format     Abstract available


  59. LU H, Stratton CW, Tang YW
    Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle.
    J Med Virol. 2020 Jan 16. doi: 10.1002/jmv.25678.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: